Biologics Regulatory Spine NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty byJosh SandbergFebruary 21, 2023
Biologics Regulatory Spine Top Stories NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company’s Thoracolumbar Interbody Portfolio byChris StewartJanuary 5, 2022
Biologics Spine Randomized Controlled Trial Results Published in ‘Spine’ Demonstrate Efficacy of NuVasive Attrax® Putty in Posterolateral Lumbar Fusion byChris StewartMarch 10, 2020
